IrmaDiz

to host the study, researchers from the Department of Mycotic Diseases laboratories for control and prevention diseases (CDC) and the Anderson MD Cancer Center at the University of Texas used the vizient clinical database to evaluate the duration of antifungal therapy (dot) per 1,000 days of patient stay overall and by years in 412 hospitals in the United States from 2018 to 2023 the year. Since cancer is a common disease in patients with invasive fungal infections (ifi), https://lwes.co.za/2021/03/25/greatest-south-african-natural-disasters/ also compared the use of antifungal drugs in polyclinics that have the status of a National Cancer Center for a comprehensive infection for the fight against cancer (nccn), and in outpatient clinics, not having an oncological center designated by nccn.